Unlocking Strategies for Navigating the Evolving Market Access Landscape: A Pharmaceutical Commerce Peer Exchange® - Episode 7

Designing Effective Value-Based Contracts: Timing, Evidence, and Risk Alignment

July 16, 2025

Edward Ahn, Rob Philo, Shana Gunderson Hua PharmD, Ed Schoonveld

Sponsored

Industry experts react to the developer’s role in preparing for value-based contracting, acknowledging that innovative agreements can support access when evidence is still maturing.

EP. 1: Current Perspective on Pricing and Reimbursement Models

EP. 2: Overcoming Regulatory Barriers to Market Access

EP. 3: Delivering Value Beyond the Trial with Real-World Evidence

EP. 4: Aligning Real-World Evidence with Payer Perspectives

EP. 5: Navigating Market Entry Challenges for Orphan Drugs

EP. 6: Effective Tactics for Pricing and Reimbursement in Today’s Market

Now Viewing

EP. 7: Designing Effective Value-Based Contracts: Timing, Evidence, and Risk Alignment

There is no shortcut to executing a value-based contract. In this episode, experts lay out what’s required to bring these agreements to life: evidence alignment, data compatibility, and mutual incentive. Payers want results, not just risk transference—and developers must understand and speak to payer business goals.

Key discussion topics include:

Timeline and prerequisites for executing value-based contracts.
Understanding what matters to payers vs. regulators.
How to prototype contracting models for early feedback.
The importance of strong head-to-head clinical data as the foundation.